Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well S-Adenosyl-L-Methionine Disulphate
P-Toluene-Sulfonate (SAMe) works compared to a placebo in preventing liver cancer in patients
with chronic hepatitis C infection. Chemoprevention is the use of certain drugs to keep
cancer from forming. The use of SAMe may keep cancer from forming in patients with advanced
liver disease
Phase:
Phase 2
Details
Lead Sponsor:
Chao Family Comprehensive Cancer Center National Cancer Institute (NCI)